Related Experiment Videos

[A case of hearing loss and diffuse alveolar hemorrhage associated with microscopic polyangitis]

Keitaro Omori1, Teppei Hoshino, Hakubun Hiramoto

  • 1Department of Internal Medicine, Kitakyusyu General Hospital.

Insights

This case highlights a rare instance of microscopic polyangiitis (MPA) presenting with both hearing loss and diffuse alveolar hemorrhage (DAH). Early diagnosis via bronchoalveolar lavage and treatment with cyclophosphamide and plasmapheresis improved pulmonary symptoms.

Area of Science:

  • Nephrology
  • Pulmonology
  • Otolaryngology

Background:

  • Microscopic polyangiitis (MPA) is a rare autoimmune vasculitis that can affect multiple organs.
  • Diffuse alveolar hemorrhage (DAH) and sensorineural hearing loss are uncommon manifestations of MPA.

Observation:

  • A 75-year-old female presented with bilateral hearing loss, followed by dyspnea and respiratory failure.
  • Chest imaging revealed bilateral consolidations, and bronchoalveolar lavage confirmed diffuse alveolar hemorrhage.
  • Laboratory findings included anemia, renal failure, and elevated myeloperoxidase-antineutrophil cytoplasmic antibodies (MPO-ANCA).

Findings:

  • The patient was diagnosed with DAH and rapidly progressive glomerulonephritis secondary to MPA.
  • Treatment with corticosteroids, cyclophosphamide pulse therapy, and plasmapheresis led to significant pulmonary improvement.
  • Hearing loss persisted despite treatment, suggesting it may be a complication of MPA.

Implications:

  • Bronchoalveolar lavage is crucial for the timely diagnosis of DAH in suspected MPA cases.
  • Early intervention with cyclophosphamide and plasmapheresis may be effective for MPA-associated DAH.
  • Bilateral hearing loss, though rare, should be considered a potential complication of MPA, even when DAH is present.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...